Guha, A.; Diaz-Pino, R.; Fagbemi, A.; Hughes, S.M.; Wynn, R.F.; Lopez-Castejon, G.; Arkwright, P.D.
Very Early-Onset IBD-Associated IL-18opathy Treated with an Anti-IL-18 Antibody. J. Clin. Med. 2024, 13, 6058.
https://doi.org/10.3390/jcm13206058
AMA Style
Guha A, Diaz-Pino R, Fagbemi A, Hughes SM, Wynn RF, Lopez-Castejon G, Arkwright PD.
Very Early-Onset IBD-Associated IL-18opathy Treated with an Anti-IL-18 Antibody. Journal of Clinical Medicine. 2024; 13(20):6058.
https://doi.org/10.3390/jcm13206058
Chicago/Turabian Style
Guha, Anthea, Rodrigo Diaz-Pino, Andrew Fagbemi, Stephen M. Hughes, Robert F. Wynn, Gloria Lopez-Castejon, and Peter D. Arkwright.
2024. "Very Early-Onset IBD-Associated IL-18opathy Treated with an Anti-IL-18 Antibody" Journal of Clinical Medicine 13, no. 20: 6058.
https://doi.org/10.3390/jcm13206058
APA Style
Guha, A., Diaz-Pino, R., Fagbemi, A., Hughes, S. M., Wynn, R. F., Lopez-Castejon, G., & Arkwright, P. D.
(2024). Very Early-Onset IBD-Associated IL-18opathy Treated with an Anti-IL-18 Antibody. Journal of Clinical Medicine, 13(20), 6058.
https://doi.org/10.3390/jcm13206058
